News Archives - Cresilon

Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply

Revolutionary hemostatic gel for veterinarians now available through Penn Vet NEW YORK (August 22, 2023) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinarians through Penn Veterinary Supply, an …

Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply Read More »

An Unorthodox Path to Medical Device Success

News / By cresilon

Med Tech Gurus Podcast

News / By cresilon

Cresilon's engineer in the Brooklyn biomanufacture

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

News, Press Releases / By cresilon

June 29, 2023, New York – Cresilon, Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for Cresilon Hemostatic Gel™ (“CHG™”). This marks Cresilon’s first FDA clearance for human use, validating its revolutionary hemostatic gel …

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology Read More »

Hemostatic Gel Immediately Stops Multiple Types of Bleeds Without Need to Apply Pressure

News / By cresilon

Aug 9, 2022 Joe Landolina is the CEO and Co-Founder of Cresilon, the only fill-and-finish operation in the five boroughs of New York. Building on a discovery about the ability to stop all kinds of bleeding, Cresilon is using recycled algae, meaning algae or kelp that has washed up onto the shoreline. The vendors they …

Hemostatic Gel Immediately Stops Multiple Types of Bleeds Without Need to Apply Pressure Read More »

Stopping Bleeding with Algal-Based Polymers

News / By cresilon

Catastrophic bleeding is a cause of death after a wide variety of wounds in humans and other animals. This week’s podcast speaks with Joe Landolina from Cresilon, describing natural polymers that immediately cease bleeding, along with their military, medical and veterinary applications. by Dr. Kevin Folta in Talking Biotech A significant number of fatalities are …

Stopping Bleeding with Algal-Based Polymers Read More »

Interview: 17-year-old invents life-saving gel technology

News / By cresilon

Posted in DDW Exclusive Content When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last …

Interview: 17-year-old invents life-saving gel technology Read More »

Two engineers in Cresilon's GMP biomanufacturing facility

Brooklyn Heights native’s company Cresilon creates gel to stop bleeding

News / By cresilon

By News 12 Staff Oct 28, 2021, 7:40amUpdated on: Oct 28, 2021, 7:40am Not many college freshmen start a business as soon as they get to school. However, Brooklyn Heights’ Joe Landolina had other plans in mind when starting his company Cresilon Inc. at NYU in 2010. Eleven years later, the company has a product that …

Brooklyn Heights native’s company Cresilon creates gel to stop bleeding Read More »